Indicators
Indicators
Value
Direction
MACD(12,26,9)
0.593
Buy
RSI(14)
60.202
Neutral
STOCH(KDJ)(9,3,3)
76.681
Buy
ATR(14)
1.579
High Vlolatility
CCI(14)
212.739
Overbought
Williams %R
0.854
Overbought
TRIX(12,20)
0.105
Sell
StochRSI(14)
100.000
Buy
Search
Alcon AG
ALCAdd to Watchlist
70.640USD
+0.020+0.03%
Market hours （ET）Quotes delayed by 15 min
34.94BMarket Cap
42.35P/E TTM
View Detailed Chart
TradingKey ChartIntraday
1m
30m
1h
D
W
M
D
Today
+0.03%
5 Days
+5.21%
1 Month
+7.29%
6 Months
-10.58%
Year to Date
-10.37%
1 Year
-18.73%
Key Figures
71.110Open
71.470High
441.24KVolume
42.35P/E TTM
18.24P/E Dynamic
0.249Dividend TTM
0.09%Turnover Ratio
70.620Prev. Close
70.550Low
18.41MTurnover
34.32P/E Static
1.58P/B
0.35%Div Yield TTM
2.62%ROA
74.34052wk High
1.02Volume Ratio
1.02BNet Profit
494.60MShares
1.6680EPS TTM
1.01Beta
3.71%ROE
47.80052wk Low
1.30%Amplitude
61.83%Gross Margin
34.94BMarket Cap
6.03Reward/Risk
1.20%Risk Rate
TradingKey Stock Score of Alcon AG
Currency: USD Updated: 2026-07-16Key Insights
Alcon AG's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 38 out of 203 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 88.47.In the medium term, the stock price is expected to trend down.Despite a good stock market performance and outperforming fundamentals over the past month, the technicals don't support the current trend.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Alcon AG's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
Alcon AG Highlights
StrengthsRisks
Alcon AG is a Switzerland-based eye care company. The Company research, develop, manufacture, distribute and sell a full suite of eye care products within two key businesses: Surgical and Vision Care. The Company’s Surgical business is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery. The surgical portfolio includes implantables, consumables and surgical equipment required for these procedures and supports the end-to-end needs of the ophthalmic surgeon. The Company’s Vision Care business comprises of daily disposable, reusable and color-enhancing contact lenses and a portfolio of ocular health products, including products for dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The Company operates in 60 countries and serves consumers and patients in over 140 countries.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 15.23%.
Fairly Valued
The company’s latest PE is 42.34, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 347.13M shares, decreasing 4.55% quarter-over-quarter.
Analyst Rating
Based on
17
analysts
Buy
Current Rating
88.470
Target Price
+28.22%
Upside Space
Alcon AG News
More news coming soon, stay tuned...
Earnings Forecast
Analyst Rating
Based on
17
analysts
Buy
Current Rating
88.470
Target Price
+28.22%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
117
Total
6
Median
9
Average
Company name
Ratings
Analysts
Alcon AG
ALC
17
Medtronic PLC
MDT
34
Dexcom Inc
DXCM
32
Stryker Corp
SYK
32
Abbott Laboratories
ABT
31
Zimmer Biomet Holdings Inc
ZBH
31
1
2
3
...
24
Indicators
Moving Average
Indicators
Value
Direction
MA5
68.558
Buy
MA10
68.135
Buy
MA20
67.343
Buy
MA50
66.490
Buy
MA100
72.333
Sell
MA200
75.171
Sell
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Alcon AG Info
Alcon AG is a Switzerland-based eye care company. The Company research, develop, manufacture, distribute and sell a full suite of eye care products within two key businesses: Surgical and Vision Care. The Company’s Surgical business is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery. The surgical portfolio includes implantables, consumables and surgical equipment required for these procedures and supports the end-to-end needs of the ophthalmic surgeon. The Company’s Vision Care business comprises of daily disposable, reusable and color-enhancing contact lenses and a portfolio of ocular health products, including products for dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The Company operates in 60 countries and serves consumers and patients in over 140 countries.
Ticker SymbolALC
CompanyAlcon AG
CEOEndicott (David J)
Websitehttps://www.alcon.ch/
Shareholders
Related Instruments
+1.09%
-1.52%
+2.65%
-0.96%
+1.54%
-11.10%
-3.18%
-0.18%
-1.28%
-1.15%
+1.40%
-1.46%
+1.35%
-1.79%
+2.66%
-0.95%
+0.15%
-2.50%
-1.76%
-1.50%Popular Instruments
52478.100
-19.600 (-0.04%)
28637.000
-344.200 (-1.19%)
7483.500
-41.600 (-0.55%)
14395.000
-446.000 (-3.00%)
64478.000
-1359.000 (-2.06%)
6212.700
-37.600 (-0.60%)
81.088
+1.809 (+2.28%)
332.580
-0.680 (-0.20%)
203.760
-3.640 (-1.76%)
3996.270
+20.710 (+0.52%)
FAQs
What is the current price of Alcon AG (ALC)?
The current price of Alcon AG (ALC) is 70.62.
What is the symbol of Alcon AG?
The ticker symbol of Alcon AG is ALC.
What is the 52-week high of Alcon AG?
The 52-week high of Alcon AG is 74.34.
What is the 52-week low of Alcon AG?
The 52-week low of Alcon AG is 47.80.
What is the market capitalization of Alcon AG?
The market capitalization of Alcon AG is 35.19B.
Is Alcon AG (ALC) currently rated as Buy, Hold, or Sell?
According to analysts, Alcon AG (ALC) has an overall rating of Buy, with a price target of 88.47.
What is the Earnings Per Share (EPS TTM) of Alcon AG (ALC)?
The Earnings Per Share (EPS TTM) of Alcon AG (ALC) is 1.99.